News | May 04, 2026
Moderna posts Q1 2026 loss despite revenue surge
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Lifts full-year outlook as obesity drug boom accelerates
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
But acquisition charges drag earnings into loss
The transaction marks a clear portfolio reshuffle for Indoco
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Subscribe To Our Newsletter & Stay Updated
